ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mecobalamin Tablet Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-7Z15311
Home | Market Reports | Health| Pharmacy
Global Mecobalamin Tablet Market Research Report 2023
BUY CHAPTERS

Global Mecobalamin Tablet Market Research Report 2025

Code: QYRE-Auto-7Z15311
Report
May 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSPC
Eisai Co Ltd
Wellona Pharma
NIKSAN PHARMACEUTICAL
North China Pharmaceutical Company Ltd.
Adipharm
Hangzhou Conba Pharmaceutical Co.,Ltd.
The global market for Mecobalamin Tablet was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
MECOBALAMIN belongs to the Vitamins class, primarily used to treat peripheral neuropathies and megaloblastic anaemia caused by vitamin B12 deficiency.
Overall, the development prospect for Mecobalamin tablets is positive, and it is expected that the demand for these tablets will continue to increase in the future. However, it is important to note that the success of any product in the market depends on factors such as quality, effectiveness, affordability, and competition from other similar products.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mecobalamin Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mecobalamin Tablet.
The Mecobalamin Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mecobalamin Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mecobalamin Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mecobalamin Tablet Market Report

Report Metric Details
Report Name Mecobalamin Tablet Market
Segment by Type
  • 500mcg
  • 1000mcg
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSPC, Eisai, Wellona Pharma, Adipharm, Niksan Pharmaceutical, Hangzhou Conba Pharmaceutical Co.,Ltd., North China Pharmaceutical Company Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mecobalamin Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mecobalamin Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Mecobalamin Tablet Market report?

Ans: The main players in the Mecobalamin Tablet Market are CSPC, Eisai, Wellona Pharma, Adipharm, Niksan Pharmaceutical, Hangzhou Conba Pharmaceutical Co.,Ltd., North China Pharmaceutical Company Ltd.

What are the Application segmentation covered in the Mecobalamin Tablet Market report?

Ans: The Applications covered in the Mecobalamin Tablet Market report are Peripheral Neuropathy, Megaloblastic Anemia, Others

What are the Type segmentation covered in the Mecobalamin Tablet Market report?

Ans: The Types covered in the Mecobalamin Tablet Market report are 500mcg, 1000mcg

Recommended Reports

Vitamin Supplements

Vitamin B Derivatives

Neuropathy and Anemia

1 Mecobalamin Tablet Market Overview
1.1 Product Definition
1.2 Mecobalamin Tablet by Type
1.2.1 Global Mecobalamin Tablet Market Value Comparison by Type (2024 VS 2031)
1.2.2 500mcg
1.2.3 1000mcg
1.3 Mecobalamin Tablet by Application
1.3.1 Global Mecobalamin Tablet Market Value by Application (2024 VS 2031)
1.3.2 Peripheral Neuropathy
1.3.3 Megaloblastic Anemia
1.3.4 Others
1.4 Global Mecobalamin Tablet Market Size Estimates and Forecasts
1.4.1 Global Mecobalamin Tablet Revenue 2020-2031
1.4.2 Global Mecobalamin Tablet Sales 2020-2031
1.4.3 Global Mecobalamin Tablet Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mecobalamin Tablet Market Competition by Manufacturers
2.1 Global Mecobalamin Tablet Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mecobalamin Tablet Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mecobalamin Tablet Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mecobalamin Tablet, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mecobalamin Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mecobalamin Tablet, Product Type & Application
2.7 Global Key Manufacturers of Mecobalamin Tablet, Date of Enter into This Industry
2.8 Global Mecobalamin Tablet Market Competitive Situation and Trends
2.8.1 Global Mecobalamin Tablet Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mecobalamin Tablet Players Market Share by Revenue
2.8.3 Global Mecobalamin Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mecobalamin Tablet Market Scenario by Region
3.1 Global Mecobalamin Tablet Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mecobalamin Tablet Sales by Region: 2020-2031
3.2.1 Global Mecobalamin Tablet Sales by Region: 2020-2025
3.2.2 Global Mecobalamin Tablet Sales by Region: 2026-2031
3.3 Global Mecobalamin Tablet Revenue by Region: 2020-2031
3.3.1 Global Mecobalamin Tablet Revenue by Region: 2020-2025
3.3.2 Global Mecobalamin Tablet Revenue by Region: 2026-2031
3.4 North America Mecobalamin Tablet Market Facts & Figures by Country
3.4.1 North America Mecobalamin Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mecobalamin Tablet Sales by Country (2020-2031)
3.4.3 North America Mecobalamin Tablet Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mecobalamin Tablet Market Facts & Figures by Country
3.5.1 Europe Mecobalamin Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mecobalamin Tablet Sales by Country (2020-2031)
3.5.3 Europe Mecobalamin Tablet Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mecobalamin Tablet Market Facts & Figures by Region
3.6.1 Asia Pacific Mecobalamin Tablet Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mecobalamin Tablet Sales by Region (2020-2031)
3.6.3 Asia Pacific Mecobalamin Tablet Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mecobalamin Tablet Market Facts & Figures by Country
3.7.1 Latin America Mecobalamin Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mecobalamin Tablet Sales by Country (2020-2031)
3.7.3 Latin America Mecobalamin Tablet Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mecobalamin Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Mecobalamin Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mecobalamin Tablet Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mecobalamin Tablet Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mecobalamin Tablet Sales by Type (2020-2031)
4.1.1 Global Mecobalamin Tablet Sales by Type (2020-2025)
4.1.2 Global Mecobalamin Tablet Sales by Type (2026-2031)
4.1.3 Global Mecobalamin Tablet Sales Market Share by Type (2020-2031)
4.2 Global Mecobalamin Tablet Revenue by Type (2020-2031)
4.2.1 Global Mecobalamin Tablet Revenue by Type (2020-2025)
4.2.2 Global Mecobalamin Tablet Revenue by Type (2026-2031)
4.2.3 Global Mecobalamin Tablet Revenue Market Share by Type (2020-2031)
4.3 Global Mecobalamin Tablet Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mecobalamin Tablet Sales by Application (2020-2031)
5.1.1 Global Mecobalamin Tablet Sales by Application (2020-2025)
5.1.2 Global Mecobalamin Tablet Sales by Application (2026-2031)
5.1.3 Global Mecobalamin Tablet Sales Market Share by Application (2020-2031)
5.2 Global Mecobalamin Tablet Revenue by Application (2020-2031)
5.2.1 Global Mecobalamin Tablet Revenue by Application (2020-2025)
5.2.2 Global Mecobalamin Tablet Revenue by Application (2026-2031)
5.2.3 Global Mecobalamin Tablet Revenue Market Share by Application (2020-2031)
5.3 Global Mecobalamin Tablet Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSPC
6.1.1 CSPC Company Information
6.1.2 CSPC Description and Business Overview
6.1.3 CSPC Mecobalamin Tablet Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSPC Mecobalamin Tablet Product Portfolio
6.1.5 CSPC Recent Developments/Updates
6.2 Eisai
6.2.1 Eisai Company Information
6.2.2 Eisai Description and Business Overview
6.2.3 Eisai Mecobalamin Tablet Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eisai Mecobalamin Tablet Product Portfolio
6.2.5 Eisai Recent Developments/Updates
6.3 Wellona Pharma
6.3.1 Wellona Pharma Company Information
6.3.2 Wellona Pharma Description and Business Overview
6.3.3 Wellona Pharma Mecobalamin Tablet Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Wellona Pharma Mecobalamin Tablet Product Portfolio
6.3.5 Wellona Pharma Recent Developments/Updates
6.4 Adipharm
6.4.1 Adipharm Company Information
6.4.2 Adipharm Description and Business Overview
6.4.3 Adipharm Mecobalamin Tablet Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Adipharm Mecobalamin Tablet Product Portfolio
6.4.5 Adipharm Recent Developments/Updates
6.5 Niksan Pharmaceutical
6.5.1 Niksan Pharmaceutical Company Information
6.5.2 Niksan Pharmaceutical Description and Business Overview
6.5.3 Niksan Pharmaceutical Mecobalamin Tablet Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Niksan Pharmaceutical Mecobalamin Tablet Product Portfolio
6.5.5 Niksan Pharmaceutical Recent Developments/Updates
6.6 Hangzhou Conba Pharmaceutical Co.,Ltd.
6.6.1 Hangzhou Conba Pharmaceutical Co.,Ltd. Company Information
6.6.2 Hangzhou Conba Pharmaceutical Co.,Ltd. Description and Business Overview
6.6.3 Hangzhou Conba Pharmaceutical Co.,Ltd. Mecobalamin Tablet Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hangzhou Conba Pharmaceutical Co.,Ltd. Mecobalamin Tablet Product Portfolio
6.6.5 Hangzhou Conba Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.7 North China Pharmaceutical Company Ltd.
6.7.1 North China Pharmaceutical Company Ltd. Company Information
6.7.2 North China Pharmaceutical Company Ltd. Description and Business Overview
6.7.3 North China Pharmaceutical Company Ltd. Mecobalamin Tablet Sales, Revenue and Gross Margin (2020-2025)
6.7.4 North China Pharmaceutical Company Ltd. Mecobalamin Tablet Product Portfolio
6.7.5 North China Pharmaceutical Company Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mecobalamin Tablet Industry Chain Analysis
7.2 Mecobalamin Tablet Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mecobalamin Tablet Production Mode & Process Analysis
7.4 Mecobalamin Tablet Sales and Marketing
7.4.1 Mecobalamin Tablet Sales Channels
7.4.2 Mecobalamin Tablet Distributors
7.5 Mecobalamin Tablet Customer Analysis
8 Mecobalamin Tablet Market Dynamics
8.1 Mecobalamin Tablet Industry Trends
8.2 Mecobalamin Tablet Market Drivers
8.3 Mecobalamin Tablet Market Challenges
8.4 Mecobalamin Tablet Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CSPC
Eisai Co Ltd
Wellona Pharma
NIKSAN PHARMACEUTICAL
North China Pharmaceutical Company Ltd.
Adipharm
Hangzhou Conba Pharmaceutical Co.,Ltd.
List of Tables
 Table 1. Global Mecobalamin Tablet Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Mecobalamin Tablet Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Mecobalamin Tablet Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Mecobalamin Tablet Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Mecobalamin Tablet Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Mecobalamin Tablet Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Mecobalamin Tablet Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Mecobalamin Tablet Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Mecobalamin Tablet, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mecobalamin Tablet, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mecobalamin Tablet, Product Type & Application
 Table 12. Global Key Manufacturers of Mecobalamin Tablet, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mecobalamin Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mecobalamin Tablet as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mecobalamin Tablet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Mecobalamin Tablet Sales by Region (2020-2025) & (K Units)
 Table 18. Global Mecobalamin Tablet Sales Market Share by Region (2020-2025)
 Table 19. Global Mecobalamin Tablet Sales by Region (2026-2031) & (K Units)
 Table 20. Global Mecobalamin Tablet Sales Market Share by Region (2026-2031)
 Table 21. Global Mecobalamin Tablet Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Mecobalamin Tablet Revenue Market Share by Region (2020-2025)
 Table 23. Global Mecobalamin Tablet Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Mecobalamin Tablet Revenue Market Share by Region (2026-2031)
 Table 25. North America Mecobalamin Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Mecobalamin Tablet Sales by Country (2020-2025) & (K Units)
 Table 27. North America Mecobalamin Tablet Sales by Country (2026-2031) & (K Units)
 Table 28. North America Mecobalamin Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Mecobalamin Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Mecobalamin Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Mecobalamin Tablet Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Mecobalamin Tablet Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Mecobalamin Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Mecobalamin Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Mecobalamin Tablet Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Mecobalamin Tablet Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Mecobalamin Tablet Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Mecobalamin Tablet Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Mecobalamin Tablet Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Mecobalamin Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Mecobalamin Tablet Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Mecobalamin Tablet Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Mecobalamin Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Mecobalamin Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Mecobalamin Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Mecobalamin Tablet Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Mecobalamin Tablet Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Mecobalamin Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Mecobalamin Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Mecobalamin Tablet Sales (K Units) by Type (2020-2025)
 Table 51. Global Mecobalamin Tablet Sales (K Units) by Type (2026-2031)
 Table 52. Global Mecobalamin Tablet Sales Market Share by Type (2020-2025)
 Table 53. Global Mecobalamin Tablet Sales Market Share by Type (2026-2031)
 Table 54. Global Mecobalamin Tablet Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Mecobalamin Tablet Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Mecobalamin Tablet Revenue Market Share by Type (2020-2025)
 Table 57. Global Mecobalamin Tablet Revenue Market Share by Type (2026-2031)
 Table 58. Global Mecobalamin Tablet Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Mecobalamin Tablet Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Mecobalamin Tablet Sales (K Units) by Application (2020-2025)
 Table 61. Global Mecobalamin Tablet Sales (K Units) by Application (2026-2031)
 Table 62. Global Mecobalamin Tablet Sales Market Share by Application (2020-2025)
 Table 63. Global Mecobalamin Tablet Sales Market Share by Application (2026-2031)
 Table 64. Global Mecobalamin Tablet Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Mecobalamin Tablet Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Mecobalamin Tablet Revenue Market Share by Application (2020-2025)
 Table 67. Global Mecobalamin Tablet Revenue Market Share by Application (2026-2031)
 Table 68. Global Mecobalamin Tablet Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Mecobalamin Tablet Price (US$/Unit) by Application (2026-2031)
 Table 70. CSPC Company Information
 Table 71. CSPC Description and Business Overview
 Table 72. CSPC Mecobalamin Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. CSPC Mecobalamin Tablet Product
 Table 74. CSPC Recent Developments/Updates
 Table 75. Eisai Company Information
 Table 76. Eisai Description and Business Overview
 Table 77. Eisai Mecobalamin Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Eisai Mecobalamin Tablet Product
 Table 79. Eisai Recent Developments/Updates
 Table 80. Wellona Pharma Company Information
 Table 81. Wellona Pharma Description and Business Overview
 Table 82. Wellona Pharma Mecobalamin Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Wellona Pharma Mecobalamin Tablet Product
 Table 84. Wellona Pharma Recent Developments/Updates
 Table 85. Adipharm Company Information
 Table 86. Adipharm Description and Business Overview
 Table 87. Adipharm Mecobalamin Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Adipharm Mecobalamin Tablet Product
 Table 89. Adipharm Recent Developments/Updates
 Table 90. Niksan Pharmaceutical Company Information
 Table 91. Niksan Pharmaceutical Description and Business Overview
 Table 92. Niksan Pharmaceutical Mecobalamin Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Niksan Pharmaceutical Mecobalamin Tablet Product
 Table 94. Niksan Pharmaceutical Recent Developments/Updates
 Table 95. Hangzhou Conba Pharmaceutical Co.,Ltd. Company Information
 Table 96. Hangzhou Conba Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 97. Hangzhou Conba Pharmaceutical Co.,Ltd. Mecobalamin Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Hangzhou Conba Pharmaceutical Co.,Ltd. Mecobalamin Tablet Product
 Table 99. Hangzhou Conba Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 100. North China Pharmaceutical Company Ltd. Company Information
 Table 101. North China Pharmaceutical Company Ltd. Description and Business Overview
 Table 102. North China Pharmaceutical Company Ltd. Mecobalamin Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. North China Pharmaceutical Company Ltd. Mecobalamin Tablet Product
 Table 104. North China Pharmaceutical Company Ltd. Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Mecobalamin Tablet Distributors List
 Table 108. Mecobalamin Tablet Customers List
 Table 109. Mecobalamin Tablet Market Trends
 Table 110. Mecobalamin Tablet Market Drivers
 Table 111. Mecobalamin Tablet Market Challenges
 Table 112. Mecobalamin Tablet Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mecobalamin Tablet
 Figure 2. Global Mecobalamin Tablet Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Mecobalamin Tablet Market Share by Type: 2024 & 2031
 Figure 4. 500mcg Product Picture
 Figure 5. 1000mcg Product Picture
 Figure 6. Global Mecobalamin Tablet Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Mecobalamin Tablet Market Share by Application: 2024 & 2031
 Figure 8. Peripheral Neuropathy
 Figure 9. Megaloblastic Anemia
 Figure 10. Others
 Figure 11. Global Mecobalamin Tablet Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Mecobalamin Tablet Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Mecobalamin Tablet Sales (2020-2031) & (K Units)
 Figure 14. Global Mecobalamin Tablet Average Price (US$/Unit) & (2020-2031)
 Figure 15. Mecobalamin Tablet Report Years Considered
 Figure 16. Mecobalamin Tablet Sales Share by Manufacturers in 2024
 Figure 17. Global Mecobalamin Tablet Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Mecobalamin Tablet Players: Market Share by Revenue in Mecobalamin Tablet in 2024
 Figure 19. Mecobalamin Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Mecobalamin Tablet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Mecobalamin Tablet Sales Market Share by Country (2020-2031)
 Figure 22. North America Mecobalamin Tablet Revenue Market Share by Country (2020-2031)
 Figure 23. United States Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Mecobalamin Tablet Sales Market Share by Country (2020-2031)
 Figure 26. Europe Mecobalamin Tablet Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Mecobalamin Tablet Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Mecobalamin Tablet Revenue Market Share by Region (2020-2031)
 Figure 34. China Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Mecobalamin Tablet Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Mecobalamin Tablet Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Mecobalamin Tablet Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Mecobalamin Tablet Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Mecobalamin Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Mecobalamin Tablet by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Mecobalamin Tablet by Type (2020-2031)
 Figure 53. Global Mecobalamin Tablet Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Mecobalamin Tablet by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Mecobalamin Tablet by Application (2020-2031)
 Figure 56. Global Mecobalamin Tablet Price (US$/Unit) by Application (2020-2031)
 Figure 57. Mecobalamin Tablet Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Mecobalamin Injection Market Research Report 2024
Mecobalamin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adenosylcobalamin Tablets Market Research Report 2024
Global Vitamin B12 Deficiency Treatment Market Research Report 2025
Vitamin B12 Cobalamin Cyanocobalamin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vitamin B12 Cobalamin Market Research Report 2024
Global Vitamin B6 Tablets Market Research Report 2024
Multivitamin Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Compound Amino Acid and Vitamin Capsule Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vitamin B1 Thiamine Mononitrate Market Insights Forecast to 2030
Cyanocobalamin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Memantine Hydrochloride Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Riboflavin Vitamin B2 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cyanocobalamin Injection Market Research Report 2024
Global Mecobalamin Market Research Report 2024
Global Cyanocobalamin Spray Market Research Report 2024
Global Vitamin B12 Series API Market Research Report 2024
Global B12 Patches Market Research Report 2024
Global Pharmaceutical Grade Vitamin B2 Market Research Report 2025
Global Vitamin B12 Drops Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions